Acinetobacter spp. isolates with reduced susceptibilities to carbapenems in a UK burns unit.
Weinbren
M J
MJ
Johnson
A P
AP
Kaufmann
M E
ME
Livermore
D M
DM
D000150:Acinetobacter / Q000187:drug effects* / Q000201:enzymology / Q000235:genetics / Q000302:isolation & purification; D002056:Burns / Q000382:microbiology*; D015780:Carbapenems / Q000494:pharmacology* / Q000627:therapeutic use; D004269:DNA, Bacterial / Q000235:genetics; D006801:Humans; D007362:Intensive Care Units; D006113:United Kingdom; D018440:beta-Lactam Resistance; D001618:beta-Lactamases / Q000737:chemistry / Q000378:metabolism
D015780:Carbapenems; D004269:DNA, Bacterial; D001618:beta-Lactamases